Chilean health authorities have ordered a recall of several batches of metformin, a widely prescribed medication used to treat type 2 diabetes, after the detection of an unidentified foreign element during routine quality control checks. The Public Health Institute of Chile (ISP) initiated the voluntary recall,which impacts prolonged-release formulations of the drug produced in india and distributed nationally,to proactively safeguard patient health. While the exact contaminant is currently under investigation, officials are urging individuals taking affected metformin to consult with their healthcare providers.
Diabetes Medication Recall Issued in Chile Due to Contamination Concerns
Health authorities in Chile have ordered a recall of a specific batch of metformin, a commonly prescribed medication for type 2 diabetes, after detecting an unidentified foreign element within the pills. The move, initiated by the Public Health Institute (ISP) of Chile, aims to prevent potential health risks for patients, according to reports.
The recall affects metformin produced in India and distributed within Chile. While the exact nature of the contaminant remains under investigation, officials acted swiftly following the discovery to remove the affected lot from the market. Metformin is a crucial medication for managing blood sugar levels in individuals with type 2 diabetes, and ensuring its safety is paramount for patient well-being.
The ISP has classified the recall as voluntary, but strongly advises individuals taking the affected medication to consult with their healthcare providers. “The ISP orders the voluntary withdrawal of prolonged-release metformin due to a sanitary risk,” Publimetro reported.
University of Austral de Chile academic, Dr. Juan Carlos Howard, emphasized the preventative nature of the recall. “This seeks to prevent potential risks to health,” according to Universidad Austral de Chile. The ISP detected the foreign element during routine quality control checks.
The recall extends to metformin tablets intended for prolonged release. Authorities are working to identify the source of the contamination and assess the extent of the affected batches. This situation highlights the importance of robust quality control measures in pharmaceutical manufacturing and supply chains to protect public health.
Chilean authorities have not yet released specific details regarding the nature of the foreign element, but investigations are ongoing. Patients with concerns are encouraged to contact their doctors or local health authorities for guidance. Mendoza Post and Noticias de Mendoza both reported on the alert.
24horas reported that the ISP initiated the recall after detecting the extraneous substance.
